Abbott Introduces Next Generation Laboratory Automation Solution to Help Meet Increased Testing Demand

Tue Apr 16, 2013 8:00am EDT

* Reuters is not responsible for the content in this press release.

Abbott Introduces Next Generation Laboratory Automation Solution to Help Meet Increased
Testing Demand

ABBOTT PARK, Illinois, April 16, 2013 /PRNewswire/ -- Abbott (NYSE : ABT) today
announced the global launch of the ACCELERATOR® a3600, a next generation automation
solution, to help laboratories address the need to process tests faster while handling
increased volume. Advances in technology and automation within the lab have led to more
timely results leading to improved patient care. Automation systems include the various
instruments, devices, and software algorithms used in laboratories.

"As laboratories around the world face challenges due to staffing shortages, budget
constraints, and increased demands, advances in automation technology such as Abbott's
ACCELERATOR a3600 can help labs be more efficient and productive," said Brian Blaser,
executive vice president, Diagnostics Products, Abbott. "Labs using automation can
achieve more than 40 percent greater efficiency, helping them adapt to meet current and
future demand, which is particularly important as approximately 70 percent of medical
decisions are informed by diagnostic testing." [1,2]

The ACCELERATOR a3600 is a laboratory automation track system that can process up to
3,600 samples per hour and handle multiple tube sizes and types simultaneously. By
automating routine, manual tasks, this system may help labs reduce error and improve
efficiency. Another advantage of the system is a modular design that offers labs the
ability to install up to 99 combined analyzers and modules on a single system, which
means that labs can address their testing needs today while planning for the future. 

The ACCELERATOR a3600 automation solution, developed with Abbott partner Swiss-based
Inpeco SA, is available worldwide pending country registration. To learn more about the
role diagnostics can play in increasing quality and efficiency in labs, please click
here
[http://www.abbott.com/static/cms_workspace/content/document/News/Features/2013/advanced-diagnostics.pdf].

Intended Use

The ACCELERATOR a3600 is a modular system designed to automate pre-analytical and
post-analytical processing, sample-handling, and processing in the laboratory. The
system consolidates multiple analytical instruments into a unified workstation by
employing a common sample processing capability. Through communication connections among
the automation system, analyzers, and the laboratory information system (LIS) or
middleware, the automation software provides workload and sample-order management, as
well as instrument operational status monitoring.

For complete information, see the product information at www.abbottdiagnostics.com
[http://www.abbottdiagnostics.com/].

About Abbott Diagnostics

Abbott is a global leader in in vitro diagnostics and offers a broad range of innovative
instrument systems and tests for hospitals, reference labs, molecular labs, blood banks,
physician offices and clinics. With more than 22,000 customers in more than 100
countries, Abbott's diagnostic products offer customers automation, convenience, bedside
testing, cost-effectiveness, and flexibility. Abbott has helped transform the practice
of medical diagnosis from an art to a science through the company's commitment to
improving patient care and lowering costs.

About Abbott

Abbott is a global healthcare company devoted to improving life through the development
of products and technologies that span the breadth of healthcare. With a portfolio of
leading, science-based offerings in diagnostics, medical devices, nutritionals and
branded generic pharmaceuticals, Abbott serves people in more than 150 countries and
employs approximately 70,000 people. 

Visit Abbott at www.abbott.com [http://www.abbott.com/] and connect with us on Twitter
at @AbbottNews.

[1]( )Rajkovich, D, Mercer, W. The Impact of Automation on Laboratory Operations. CHI
Solutions 2009; 1-3.

[2] Diagnostics and Policy: Innovation and Value. AdvaMedDX.org. Accessed March 7, 2013.

Abbott

CONTACT:  Media, Darcy Ross, (847) 937-3655, or Jessica Masuga, (847)
935-0650; or Financial, Tina Ventura, (847) 935-9390 

Web site:  http://www.abbott.com/
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.